TrialJournal of the American Society of Nephrology : JASN2017

A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.

Richard A Lafayette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.